Literature DB >> 30049777

Minimising iatrogenic nerve injury in primary care.

Katharine A Wallis1, Thomas Hills2, S Ali Mirjalili3.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30049777      PMCID: PMC6058644          DOI: 10.3399/bjgp18X698273

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  6 in total

1.  Ultrasound visualization of the spinal accessory nerve in vivo.

Authors:  Seyed A Mirjalili; Jill C Muirhead; Mark D Stringer
Journal:  J Surg Res       Date:  2011-11-21       Impact factor: 2.192

2.  No-fault compensation for treatment injury in New Zealand: identifying threats to patient safety in primary care.

Authors:  Katharine Wallis; Susan Dovey
Journal:  BMJ Qual Saf       Date:  2011-01-12       Impact factor: 7.035

Review 3.  Sciatic nerve injury from intramuscular injection: a persistent and global problem.

Authors:  P Mishra; M D Stringer
Journal:  Int J Clin Pract       Date:  2010-10       Impact factor: 2.503

4.  Revisiting the surface anatomy of the sciatic nerve in the gluteal region.

Authors:  Stephen S Currin; S Ali Mirjalili; Grant Meikle; Mark D Stringer
Journal:  Clin Anat       Date:  2014-08-08       Impact factor: 2.414

Review 5.  Iatrogenic upper limb nerve injuries: a systematic review.

Authors:  John Zhang; Abigail E Moore; Mark D Stringer
Journal:  ANZ J Surg       Date:  2010-12-23       Impact factor: 1.872

6.  Iatrogenic axillary neuropathy after intramuscular injection of the deltoid muscle.

Authors:  Loren T Davidson; Gregory T Carter; David D Kilmer; Jay J Han
Journal:  Am J Phys Med Rehabil       Date:  2007-06       Impact factor: 2.159

  6 in total
  2 in total

1.  Implementation of Ultrasound in Anatomy Education.

Authors:  C F Smith; S Barfoot
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Minimising iatrogenic nerve injury in primary care.

Authors:  Sam Rowlands
Journal:  Br J Gen Pract       Date:  2018-09       Impact factor: 5.386

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.